364 related articles for article (PubMed ID: 8453632)
21. ACB-PCR measurement of K-ras codon 12 mutant fractions in livers of Big Blue rats treated with N-hydroxy-2-acetylaminofluorene.
McKinzie PB; Delongchamp RR; Chen T; Parsons BL
Mutagenesis; 2006 Nov; 21(6):391-7. PubMed ID: 17012303
[TBL] [Abstract][Full Text] [Related]
22. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
23. p21Ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between ras-mutated and ras-wild-type lesions.
Kalkuhl A; Troppmair J; Buchmann A; Stinchcombe S; Buenemann CL; Rapp UR; Kaestner K; Schwarz M
Hepatology; 1998 Apr; 27(4):1081-8. PubMed ID: 9537449
[TBL] [Abstract][Full Text] [Related]
24. Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2.
Przygodzki RM; Finkelstein SD; Keohavong P; Zhu D; Bakker A; Swalsky PA; Soini Y; Ishak KG; Bennett WP
Lab Invest; 1997 Jan; 76(1):153-9. PubMed ID: 9010458
[TBL] [Abstract][Full Text] [Related]
25. Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice.
Horio Y; Chen A; Rice P; Roth JA; Malkinson AM; Schrump DS
Mol Carcinog; 1996 Dec; 17(4):217-23. PubMed ID: 8989915
[TBL] [Abstract][Full Text] [Related]
26. Harvey ras (H-ras) point mutations are induced by 4-nitroquinoline-1-oxide in murine oral squamous epithelia, while squamous cell carcinomas and loss of heterozygosity occur without additional exposure.
Yuan B; Heniford BW; Ackermann DM; Hawkins BL; Hendler FJ
Cancer Res; 1994 Oct; 54(20):5310-7. PubMed ID: 7923158
[TBL] [Abstract][Full Text] [Related]
27. DNA adduct measurements, cell proliferation and tumor mutation induction in relation to tumor formation in B6C3F1 mice fed coal tar or benzo[a]pyrene.
Culp SJ; Warbritton AR; Smith BA; Li EE; Beland FA
Carcinogenesis; 2000 Jul; 21(7):1433-40. PubMed ID: 10874023
[TBL] [Abstract][Full Text] [Related]
28. Analysis of activated protooncogenes in B6C3F1 mouse liver tumors induced by ciprofibrate, a potent peroxisome proliferator.
Hegi ME; Fox TR; Belinsky SA; Devereux TR; Anderson MW
Carcinogenesis; 1993 Jan; 14(1):145-9. PubMed ID: 8425263
[TBL] [Abstract][Full Text] [Related]
29. Frequent mutations of the Trp53, Hras1 and beta-catenin (Catnb) genes in 1,3-butadiene-induced mammary adenocarcinomas in B6C3F1 mice.
Zhuang SM; Wiseman RW; Söderkvist P
Oncogene; 2002 Aug; 21(36):5643-8. PubMed ID: 12165863
[TBL] [Abstract][Full Text] [Related]
30. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products.
Suzuki Y; Orita M; Shiraishi M; Hayashi K; Sekiya T
Oncogene; 1990 Jul; 5(7):1037-43. PubMed ID: 2197591
[TBL] [Abstract][Full Text] [Related]
31. Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation.
Hegi ME; Devereux TR; Dietrich WF; Cochran CJ; Lander ES; Foley JF; Maronpot RR; Anderson MW; Wiseman RW
Cancer Res; 1994 Dec; 54(23):6257-64. PubMed ID: 7954475
[TBL] [Abstract][Full Text] [Related]
32. Spontaneous and thiazolidinedione-induced B6C3F1 mouse hemangiosarcomas exhibit low ras oncogene mutation frequencies.
Duddy SK; Gorospe SM; Bleavins MR; de la Iglesia FA
Toxicol Appl Pharmacol; 1999 Oct; 160(2):133-40. PubMed ID: 10527912
[TBL] [Abstract][Full Text] [Related]
33. Mutations in ras genes in experimental tumours of rodents.
Sills RC; Boorman GA; Neal JE; Hong HL; Devereux TR
IARC Sci Publ; 1999; (146):55-86. PubMed ID: 10353384
[TBL] [Abstract][Full Text] [Related]
34. Levels of 4-aminobiphenyl-induced somatic H-ras mutation in mouse liver DNA correlate with potential for liver tumor development.
Parsons BL; Beland FA; Von Tungeln LS; Delongchamp RR; Fu PP; Heflich RH
Mol Carcinog; 2005 Apr; 42(4):193-201. PubMed ID: 15761837
[TBL] [Abstract][Full Text] [Related]
35. Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors.
Aydinlik H; Nguyen TD; Moennikes O; Buchmann A; Schwarz M
Oncogene; 2001 Nov; 20(53):7812-6. PubMed ID: 11753661
[TBL] [Abstract][Full Text] [Related]
36. B-raf and Ha-ras mutations in chemically induced mouse liver tumors.
Jaworski M; Buchmann A; Bauer P; Riess O; Schwarz M
Oncogene; 2005 Feb; 24(7):1290-5. PubMed ID: 15592514
[TBL] [Abstract][Full Text] [Related]
37. Identification of point mutations at codon 61 of the c-Ha-ras gene by single-strand conformation polymorphism analysis.
Bauer-Hofmann R; Kress S; Schwarz M
Biotechniques; 1992 Aug; 13(2):192-4. PubMed ID: 1389147
[No Abstract] [Full Text] [Related]
38. Low frequency of H-ras activation in naturally occurring hepatocellular tumors of C3H/HeNCr mice.
Enomoto T; Weghorst CM; Ward JM; Anderson LM; Perantoni AO; Rice JM
Carcinogenesis; 1993 Sep; 14(9):1939-44. PubMed ID: 8403222
[TBL] [Abstract][Full Text] [Related]
39. Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors.
Ichikawa Y; Nishida M; Suzuki H; Yoshida S; Tsunoda H; Kubo T; Uchida K; Miwa M
Cancer Res; 1994 Jan; 54(1):33-5. PubMed ID: 8261457
[TBL] [Abstract][Full Text] [Related]
40. Selective mutation of K-ras by N-ethylnitrosourea shifts from codon 12 to codon 61 during fetal mouse lung maturation.
Sithanandam G; Ramakrishna G; Diwan BA; Anderson LM
Oncogene; 1998 Jul; 17(4):493-502. PubMed ID: 9696043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
